In light of the recent surge in demand of pain relief

Question

In light of the recent surge in demand for pain relief medications and the promising results of clinical trials, pharmaceutical companies are rushing to develop a new product called Tyleone. However, there are concerns about potential risks associated with its introduction to the market. To assess the viability of Tyleone's launch and the potential impact on the pharmaceutical industry, thorough evaluation and consideration of various factors are necessary. 
 
In evaluating the potential success of introducing the pharmaceutical product Tyleone to the market, which of the following inquiries would be most pertinent?

(A) Does the manufacturing process of Tyleone involve environmentally sustainable practices?
(B) Could the introduction of Tyleone lead to increased competition in the pain relief medication market?
(C) Are there any regulations in place regarding the advertising of pharmaceutical products like Tyleone?
(D) Are there established distribution channels for pharmaceutical products similar to Tyleone in the target market?
(E) Were there other factors in previous pharmaceutical product launches that could impact the success of Tyleone and make direct comparisons less meaningful?

sansun · Answer

I think the answer is B.

Because competition directly affects whether the product is likely to succeed and how it will affect the industry. More competition influences pricing, market share, profitability, and adoption. 
Also, options A & E are questions that provide context, but they are themes that don't directly determine market success. 
For (C) Advertising regulations matter, but they are only one operational consideration. 
And for (D) Distribution channels are relevant, but the passage focuses on overall viability and industry impact, making competition more central.

officiisnobis · Answer

I think the answer is D because if there are no distribution channels then how can will it be successful in the market. No one will buy the product.

guddo · Answer

In light of the recent surge in demand for pain relief medications and the promising results of clinical trials, pharmaceutical companies are rushing to develop a new product called Tyleone. However, there are concerns about potential risks associated with its introduction to the market. To assess the viability of Tyleone's launch and the potential impact on the pharmaceutical industry, thorough evaluation and consideration of various factors are necessary. 
 
In evaluating the potential success of introducing the pharmaceutical product Tyleone to the market, which of the following inquiries would be most pertinent?

The passage says Tyleone may have strong market potential because demand is high and clinical trials are promising. But to evaluate whether the product can succeed in the market, we need to know whether it can actually reach customers effectively.  The key practical issue  is whether there are proper  distribution channels .

(A) Does the manufacturing process of Tyleone involve environmentally sustainable practices?

This may matter ethically or reputationally, but it is not the most direct issue for evaluating market success.

(B) Could the introduction of Tyleone lead to increased competition in the pain relief medication market?

This concerns the product’s possible effect on the market, but it does not directly tell us whether Tyleone itself will succeed.

(C) Are there any regulations in place regarding the advertising of pharmaceutical products like Tyleone?

This is relevant, but narrower. Advertising rules matter, but they are not as basic as whether the product can be distributed in the target market.

(D) Are there established distribution channels for pharmaceutical products similar to Tyleone in the target market?

This is correct. Even if demand is high and trials are promising, Tyleone’s launch depends on whether the product can be delivered through established channels to pharmacies, hospitals, or consumers. Without distribution, market success is unlikely.

(E) Were there other factors in previous pharmaceutical product launches that could impact the success of Tyleone and make direct comparisons less meaningful?

This is too vague. The passage does not base its argument on comparison with previous launches, so this is not the most pertinent inquiry.

Answer: (D)

alamin8 · Answer

I really like your thought process. I agree that without a distribution channel, people don't know where to buy. Therefore, it is D.

In light of the recent surge in demand of pain relief

Prep Toolkit

Top 5 GMAT Debrief Videos

615 to 715 in 15 Days (Ria's Strategies)

More than Quant/Verbal Abilities: Speed vs. Accuracy

745 with Only Self-Prep and GMAT Club

From 555 to 765: 210-point Improvement

Perfect 805 Score Debrief by Julia

My Rewards

GMAT Critical Reasoning (CR) Questions

In light of the recent surge in demand of pain relief

Prep Toolkit

615 to 715 in 15 Days (Ria's Strategies)

More than Quant/Verbal Abilities: Speed vs. Accuracy

745 with Only Self-Prep and GMAT Club

From 555 to 765: 210-point Improvement

Perfect 805 Score Debrief by Julia

My Rewards